Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas-Reference-Cited by-同舟云学术

Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas

Published:2020-02 Issue:2 Volume:106 Page:340-348
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cheng Ningning,Liu Yong,Zhao Guoqi,Xu Yi,Zhang Tiening,Chen Ying,Yan Ge,Hu Ye,Yao Shengyu,Wang Zijie,Wang Chungang,Chen Zhixiao,Hu Zhekai,Liu Dongli,Chen Tingfeng

Funder

National Natural Science Foundation of China

Shanghai Municipal Commission of Health and Family Planning

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference36 articles.

1. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus;Herskovic;N Engl J Med,1992

2. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01);Cooper;JAMA,1999

3. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study;Al-Sarraf;J Clin Oncol,1997

4. Oesophageal carcinoma;Pennathur;Lancet,2013

5. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report;Gaspar;Int J Radiat Oncol Biol Phys,1997

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses;Radiotherapy and Oncology;2021-11